Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Marsden

Showing results (621-630 of 1,050) with videos related to

Pageof 105
Sort By:
Brain : a Journal of Neurology|October 1, 1994
Corticobasal degeneration. A clinical study of 36 casesJ O Rinne, M S Lee, P D Thompson, et al.
Lancet (London, England)|June 14, 1986
Painful Parkinson's diseaseN P Quinn, W C Koller, A E Lang, et al.
Biochemical Pharmacology|May 1, 1991
Acute effects of D-1 and D-2 dopamine receptor agonist and antagonist drugs on basal ganglia [Met5]- and [Leu5]-enkephalin and neurotensin content in the ratM D Taylor, M L de Ceballos, P Jenner, et al.
Annals of Neurology|March 1, 1991
A genetic study of idiopathic focal dystoniasH M Waddy, N A Fletcher, A E Harding, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 1, 1977
Behavioural and biochemical effects of chronic reduction of cerebral noradrenaline receptor stimulationA Dolphin, M Christina, M C Sawaya, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|April 1, 1997
Corticospinal function in conversion disorderJ Foong, M Ridding, H Cope, et al.
Neurology|June 20, 1998
Electrophysiological aids in distinguishing organic from psychogenic tremorJ H McAuley, J C Rothwell, C D Marsden, et al.
Advances in Neurology|January 1, 1986
Toxic myoclonusJ A Obeso, C Viteri, J M Martínez Lage, et al.
Lancet (London, England)|August 26, 1972
Amantadine in migraineR C Baxter, C D Marsden, J D Parkes, et al.
British Journal of Clinical Pharmacology|October 1, 1978
Plasma bromocriptine levels, clinical and growth hormone responses in ParkinsonismP Price, A Debono, J D Parkes, et al.
Pageof 105

Showing results (621-630 of 1,050) with videos related to

Sort By:
Pageof 105
Brain : a Journal of Neurology|October 1, 1994
Corticobasal degeneration. A clinical study of 36 casesJ O Rinne, M S Lee, P D Thompson, et al.
Lancet (London, England)|June 14, 1986
Painful Parkinson's diseaseN P Quinn, W C Koller, A E Lang, et al.
Biochemical Pharmacology|May 1, 1991
Acute effects of D-1 and D-2 dopamine receptor agonist and antagonist drugs on basal ganglia [Met5]- and [Leu5]-enkephalin and neurotensin content in the ratM D Taylor, M L de Ceballos, P Jenner, et al.
Annals of Neurology|March 1, 1991
A genetic study of idiopathic focal dystoniasH M Waddy, N A Fletcher, A E Harding, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 1, 1977
Behavioural and biochemical effects of chronic reduction of cerebral noradrenaline receptor stimulationA Dolphin, M Christina, M C Sawaya, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|April 1, 1997
Corticospinal function in conversion disorderJ Foong, M Ridding, H Cope, et al.
Neurology|June 20, 1998
Electrophysiological aids in distinguishing organic from psychogenic tremorJ H McAuley, J C Rothwell, C D Marsden, et al.
Advances in Neurology|January 1, 1986
Toxic myoclonusJ A Obeso, C Viteri, J M Martínez Lage, et al.
Lancet (London, England)|August 26, 1972
Amantadine in migraineR C Baxter, C D Marsden, J D Parkes, et al.
British Journal of Clinical Pharmacology|October 1, 1978
Plasma bromocriptine levels, clinical and growth hormone responses in ParkinsonismP Price, A Debono, J D Parkes, et al.
Pageof 105